ARTICLE | Company News
Ipsen, Nestle deal
January 25, 2016 8:00 AM UTC
Ipsen and Nestle’s Galderma unit again amended a 2007 deal. Ipsen now granted Galderma exclusive rights to develop and commercialize Dysport abobotulinumtoxinA for aesthetic use in China, India, Sout...